Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$85K Buy
578
+256
+80% +$41.6K 0.02% 235
2025
Q4
$62.8K Buy
322
+8
+3% +$1.91K 0.01% 260
2025
Q3
$88.3K Hold
314
0.02% 210
2025
Q2
$68.7K Hold
314
0.02% 206
2025
Q1
$43.9K Buy
314
+105
+50% +$17.1K 0.01% 220
2024
Q4
$34.8K Sell
209
-10,314
-98% -$1.83M 0.01% 238
2024
Q3
$1.79M Hold
10,523
0.58% 22
2024
Q2
$1.49M Hold
10,523
0.53% 23
2024
Q1
$1.32M Hold
10,523
0.45% 28
2023
Q4
$1.11M Hold
10,523
0.44% 25
2023
Q3
$1.11M Hold
10,523
0.44% 26
2023
Q2
$1.25M Buy
10,523
+8,989
+586% +$929K 0.57% 23
2023
Q1
$143K Buy
1,534
+1,398
+1,028% +$123K 0.07% 93
2022
Q4
$11.1K Buy
+136
New +$10.3K 0.01% 269
2022
Q3
Sell
-295
Closed -$21K 347
2022
Q2
$21K Hold
295
0.01% 198
2022
Q1
$24K Hold
295
0.02% 197
2021
Q4
$26K Buy
+295
New +$27.7K 0.02% 186

Other funds holding ORCL

Operose Advisors's ORCL Position: Q1 2026 in Review

Operose Advisors increased its Oracle (ORCL) stake by 80% in Q1 2026, buying an estimated $41.6K and bringing the position to 578 shares worth $85K. The position accounts for 0.02% of the portfolio, ranked #235.

Operose Advisors first reported a position in ORCL in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.79M in Q3 2024. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Operose Advisors held 578 shares of Oracle worth $85K as of Q1 2026.
  • Operose Advisors bought 256 Oracle shares in Q1 2026, an estimated $41.6K.
  • Oracle made up 0.02% of Operose Advisors's portfolio in Q1 2026, its #235 holding.
  • Operose Advisors first reported a position in Oracle in Q4 2021 and has held it in 17 quarters since.
  • Operose Advisors's Oracle position peaked at $1.79M in Q3 2024.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Operose Advisors's 13F filing for Q1 2026, filed 12 May 2026.